(Q35128999)

6 August 2017

1 reference

title

Dialysis-related carnitine disorder and levocarnitine pharmacology (English)

1 reference

6 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

3 January 2024

author name string

Allan Evans

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12751050

3 January 2024

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0272638603001136?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

https://api.elsevier.com/content/article/PII:S0272638603001136?httpAccept=text/plain

3 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

American Journal of Kidney Diseases

3 January 2024

published in

1 reference

6 August 2017

41

1 reference

6 August 2017

4 Suppl 4

1 reference

6 August 2017

S13-26

1 reference

Carnitine--metabolism and functions

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine metabolism and function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine metabolism and its regulation in microorganisms and mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine status of lactoovovegetarians and strict vegetarian adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine and acetylcarnitine in red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Quantitative estimation of absorption and degradation of a carnitine supplement by human adults

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine biosynthesis in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Primary systemic carnitine deficiency. II. Renal handling of carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Renal adaptation to dietary carnitine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine deficiency induced during intermittent haemodialysis for renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Pharmacokinetics of L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine metabolism during exercise in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Plasma and muscle carnitine levels in haemodialysis patients with morphological-ultrastructural examination of muscle samples

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Kinetics of intravenously administered carnitine in haemodialysed children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

L-carnitine and haemodialysis: double blind study on muscle function and metabolism and peripheral nerve function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Biochemical profile or uremic breath

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Carnitine kinetics during dialysis. Evidence of unilateral transport from tissues to plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900113-6

7 January 2021

Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man

13

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

Protein binding of L-carnitine family components

3 January 2024

15

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

3 January 2024

carnitine transport

21

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

Quantitative assessment of carnitine loss during hemodialysis and hemofiltration

3 January 2024

29

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

Studies of carnitine metabolism in relation to intestinal absorption

3 January 2024

48

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

Metabolism and toxicity of aliphatic amines

3 January 2024

49

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

Toxicity of aliphatic amines in uremia

3 January 2024

51

1 reference

https://api.crossref.org/works/10.1016/S0272-6386(03)00113-6

3 January 2024

Identifiers

1 reference

6 August 2017

1 reference